Tag: Frederik Paulsen

Ferring, Blackstone invest $570m in nadofaragene firadenovec gene therapy

pharmanewsdaily- November 26, 2019

Ferring Pharmaceuticals, a Swiss specialty biopharmaceutical group, has teamed up with private investment platform Blackstone Life Sciences to jointly invest more than $570 million in ... Read More